{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:43:55Z","timestamp":1772754235323,"version":"3.50.1"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/mph.0b013e31828f8746","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T13:24:02Z","timestamp":1366723442000},"page":"245-252","source":"Crossref","is-referenced-by-count":29,"title":["Biology of Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"35","author":[{"given":"Luca","family":"Lo Nigro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.","volume":"24","author":"Conter","year":"2010","journal-title":"Leukemia"},{"key":"R2-2-20210227","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","article-title":"Biology, Risk stratification and therapy of Pediatric leukemias: an update.","volume":"29","author":"Pui","year":"2011","journal-title":"J Clin Oncol"},{"key":"R3-2-20210227","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2012.01.007","article-title":"Perspectives on the causes of childhood leukemia.","volume":"196","author":"Wiemels","year":"2012","journal-title":"Chem Biol Interact"},{"key":"R4-2-20210227","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.beha.2011.09.004","article-title":"Genomic profiling of B-progenitor acute lymphoblastic leukemia.","volume":"24","author":"Mullighan","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"R6-2-20210227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/rpd\/ncn259","article-title":"Incidence, time trends and regional variation of childhood leukaemia in Germany and Europe.","volume":"132","author":"Kaatsch","year":"2008","journal-title":"Radiat Prot Dosimetry"},{"key":"R8-2-20210227","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/gcc.10199","article-title":"Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California.","volume":"37","author":"McHale","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"R9-2-20210227","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(99)09403-9","article-title":"Prenatal origin of acute lymphoblastic leukaemia in children.","volume":"354","author":"Wiemels","year":"1999","journal-title":"Lancet"},{"key":"R10-2-20210227","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/gcc.20003","article-title":"Protracted postnatal natural histories in childhood leukemia.","volume":"39","author":"Maia","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"R11-2-20210227","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood-2010-10-313791","article-title":"Novel association between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia.","volume":"118","author":"Almante","year":"2011","journal-title":"Blood"},{"key":"R12-2-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1995.1","article-title":"Epidemiological evidence for an infective basis in childhood leukaemia.","volume":"71","author":"Kinlen","year":"1995","journal-title":"Br J Cancer"},{"key":"R13-2-20210227","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","article-title":"Infection, immune responses and the aetiology of childhood leukaemia.","volume":"6","author":"Greaves","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R14-2-20210227","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1182\/blood-2011-07-366542","article-title":"Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph acute lymphoblastic leukaemia.","volume":"118","author":"Cazzaniga","year":"2011","journal-title":"Blood"},{"key":"R15-2-20210227","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2010-09-309070","article-title":"ETV6RUNX1 (TELAML1) is a frequent prenatal first hit in childhood leukemia.","volume":"117","author":"Zuna","year":"2011","journal-title":"Blood"},{"key":"R16-2-20210227","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1073\/pnas.112218799","article-title":"Chromosome translocations and covert leukemic clones are generated during normal fetal development.","volume":"99","author":"Mori","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-2-20210227","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood-2002-12-3817","article-title":"Leukemia in Twins: lessons in natural history.","volume":"102","author":"Greaves","year":"2003","journal-title":"Blood"},{"key":"R18-2-20210227","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"R19-2-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.","volume":"10","author":"den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"R20-2-20210227","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"R21-2-20210227","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpeds.2011.08.006","article-title":"Clinical and laboratory biology of childhood acute lymphoblastic leukemia.","volume":"160","author":"Carrol","year":"2012","journal-title":"J Pediatr"},{"key":"R22-2-20210227","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08880019209018329","article-title":"Leukemia in Down syndrome: a review.","volume":"9","author":"Zipursky","year":"1999","journal-title":"Pediatr Hematol Oncol"},{"key":"R23-2-20210227","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1182\/blood-2007-09-114231","article-title":"Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.","volume":"111","author":"Forestier","year":"2008","journal-title":"Blood"},{"key":"R24-2-20210227","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","article-title":"Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.","volume":"115","author":"Hertzberg","year":"2010","journal-title":"Blood"},{"key":"R25-2-20210227","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood-2009-07-235291","article-title":"Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Childrens Oncology Group.","volume":"116","author":"Maloney","year":"2010","journal-title":"Blood"},{"key":"R26-2-20210227","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"key":"R27-2-20210227","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","article-title":"Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Childrens Oncology Group Study.","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"R28-2-20210227","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ng.432","article-title":"Germline genomic variants associated with childhood acute lymphoblastic leukemia.","volume":"41","author":"Trevino","year":"2009","journal-title":"Nat Genet"},{"key":"R29-2-20210227","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.430","article-title":"Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.","volume":"41","author":"Papaemmanuil","year":"2009","journal-title":"Nat Genet"},{"key":"R30-2-20210227","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/leu.2011.302","article-title":"Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.","volume":"26","author":"Ellinghaus","year":"2012","journal-title":"Leukemia"},{"key":"R31-2-20210227","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","article-title":"Cytogenetics of paediatric and adolescent acute lymphoblastic leukemia.","volume":"144","author":"Harrison","year":"2009","journal-title":"Br J Haematol"},{"key":"R32-2-20210227","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL9799 randomised trial.","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"key":"R33-2-20210227","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","article-title":"Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.","volume":"28","author":"Arico","year":"2010","journal-title":"J Clin Oncol"},{"key":"R34-2-20210227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.seminhematol.2008.09.006","article-title":"New genetic abnormalities and treatment response in acute lymphoblastic leukemia.","volume":"46","author":"Meijerink","year":"2009","journal-title":"Semin Hematol"},{"key":"R35-2-20210227","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"R36-2-20210227","first-page":"631","article-title":"Detection of CALMAF10 fusion transcript does not predict a poor outcome in children with T-lineage acute lymphoblastic leukemia treated with AIEOP ALL 2000 protocol and subsequent modified 2000 study (R-2006). American Society of Hematology (ASH) 51st Annual Meeting 5-8 December, New Orleans abstract 1578.","volume":"114","author":"Lo Nigro","year":"2009","journal-title":"Blood"},{"key":"R37-2-20210227","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"R38-2-20210227","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/leu.2011.46","article-title":"Targeting the translational apparatus to improve leukemia therapy: roles of PI3KPTENAKTmTOR pathway.","volume":"25","author":"Martelli","year":"2011","journal-title":"Leukemia"},{"key":"R40-2-20210227","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.","volume":"342","author":"Arico","year":"2000","journal-title":"N Engl J Med"},{"key":"R41-2-20210227","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a childrens oncology group study.","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"R42-2-20210227","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"R43-2-20210227","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias.","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"issue":"suppl 2","key":"R44-2-20210227","first-page":"259","article-title":"Outcome of children (Non-Infant) with t(4;11) positive acute lymphoblastic leukemia treated with AIEOP-LLA 2000-R2006 protocols. 15th Congress of the European Hematology Association (EHA), Barcelona, June 10-13 abstract 0617.","volume":"95","author":"Lo Nigro","year":"2010","journal-title":"Haematologica"},{"key":"R45-2-20210227","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.beha.2011.09.004","article-title":"Genomic profiling of B-progenitor acute lymphoblastic leukemia.","volume":"24","author":"Mullighan","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"R46-2-20210227","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1158\/0008-5472.CAN-07-2778","article-title":"PAX5TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.","volume":"68","author":"Fazio","year":"2008","journal-title":"Cancer Res"},{"key":"R47-2-20210227","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia.","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R48-2-20210227","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1182\/blood-2011-01-329961","article-title":"Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.","volume":"117","author":"Rand","year":"2011","journal-title":"Blood"},{"key":"R49-2-20210227","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"R50-2-20210227","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/leu.2009.17","article-title":"Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.","volume":"23","author":"Van der Velden","year":"2009","journal-title":"Leukemia"},{"key":"R51-2-20210227","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"key":"R52-2-20210227","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0609.2009.01305.x","article-title":"Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients.","volume":"85","author":"Trentin","year":"2009","journal-title":"Eur J Haematol"},{"key":"R53-2-20210227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/leu.2010.232","article-title":"Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients.","volume":"25","author":"Bardini","year":"2011","journal-title":"Leukemia"},{"key":"R55-2-20210227","first-page":"114","article-title":"In infant ALL with t(4;11)MLL-AF4 multiple and phenotypically distinct CD19 BM subsets initiate leukemia in NODSCID Mice. American Society of Hematology (ASH) 51st Annual Meeting abstract 1432.","volume":"582","author":"Bardini","year":"2009","journal-title":"Blood"},{"key":"R56-2-20210227","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2008.07314.x","article-title":"Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.","volume":"143","author":"Van Vlierberghe","year":"2008","journal-title":"Br J Haematol"},{"key":"R57-2-20210227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.seminhematol.2008.09.006","article-title":"New genetic abnormalities and treatment response in acute lymphoblastic leukemia.","volume":"46","author":"Meijerink","year":"2009","journal-title":"Semin Hematol"},{"key":"R58-2-20210227","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"R59-2-20210227","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1200\/JCO.2010.30.2877","article-title":"Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.","volume":"29","author":"Szczepanski","year":"2011","journal-title":"J Clin Oncol"},{"key":"R60-2-20210227","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.leu.2401269","article-title":"Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years from diagnosis.","volume":"13","author":"Lo Nigro","year":"1999","journal-title":"Leukemia"},{"key":"R61-2-20210227","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia.","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"R62-2-20210227","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","article-title":"Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.","volume":"118","author":"Hogan","year":"2011","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e31828f8746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:15:22Z","timestamp":1620965722000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201305000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31828f8746","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}